Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


Articles published in Rheumatol Int

Retrieve available abstracts of 275 articles:
HTML format



Single Articles


    August 2021
  1. MACIVER A, Hollinger H, Carolan C
    Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review.
    Rheumatol Int. 2021;41:1399-1418.
    PubMed     Abstract available


    July 2021
  2. ZURA N, Vukorepa M, Jurak I, Peric P, et al
    Decrease in handgrip strength in rheumatoid arthritis (RA): is there a sex-related difference?
    Rheumatol Int. 2021 Jul 28. pii: 10.1007/s00296-021-04959.
    PubMed     Abstract available


  3. BARIK RR, Bhatt LK
    Emerging epigenetic targets in rheumatoid arthritis.
    Rheumatol Int. 2021 Jul 26. pii: 10.1007/s00296-021-04951.
    PubMed     Abstract available


  4. JOHNSTONE G, Treharne GJ, Fletcher BD, Lamar RSM, et al
    Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown.
    Rheumatol Int. 2021 Jul 23. pii: 10.1007/s00296-021-04952.
    PubMed     Abstract available


  5. MULLER K, Kuipers JG, Weis J, Fischer I, et al
    Self-reported fatigue in patients with rheumatoid arthritis compared to patients with cancer: results from two large-scale studies.
    Rheumatol Int. 2021 Jul 16. pii: 10.1007/s00296-021-04948.
    PubMed     Abstract available


  6. HONNE K, Bando M, Mieno MN, Iwamoto M, et al
    Bronchiectasis is as crucial as interstitial lung disease in the severe pneumonia that occurs during treatment with biologic DMARDs in rheumatoid arthritis: a retrospective cohort study in a single facility.
    Rheumatol Int. 2021 Jul 12. pii: 10.1007/s00296-021-04934.
    PubMed     Abstract available


  7. NAKAJIMA T, Watanabe R, Hashimoto M, Murata K, et al
    Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients.
    Rheumatol Int. 2021 Jul 9. pii: 10.1007/s00296-021-04944.
    PubMed     Abstract available


  8. YAGIZ B, Coskun BN, Pehlivan Y, Dalkilic E, et al
    In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
    Rheumatol Int. 2021 Jul 5. pii: 10.1007/s00296-021-04939.
    PubMed     Abstract available


  9. CHEVALLARD M, Belloli L, Ughi N, Adinolfi A, et al
    Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting.
    Rheumatol Int. 2021;41:1253-1261.
    PubMed     Abstract available


    June 2021
  10. OULKADI L, Rostom S, Hmamouchi I, El Hassani Sbai S, et al
    Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry.
    Rheumatol Int. 2021 Jun 26. pii: 10.1007/s00296-021-04929.
    PubMed     Abstract available


  11. GOMEZ-GALICIA DL, Aguilar-Castillo J, Garcia-Garcia C, Moctezuma-Rios JF, et al
    Qualitative validation of audiovisual educational material for use on rheumatoid arthritis patients.
    Rheumatol Int. 2021 Jun 19. pii: 10.1007/s00296-021-04921.
    PubMed     Abstract available


  12. TANAKA K, Kimura E, Oryoji K, Mizuki SI, et al
    Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database.
    Rheumatol Int. 2021 Jun 6. pii: 10.1007/s00296-021-04889.
    PubMed     Abstract available


    May 2021
  13. FAYET F, Pereira B, Fan A, Rodere M, et al
    Therapeutic education improves rheumatoid arthritis patients' knowledge about methotrexate: a single center retrospective study.
    Rheumatol Int. 2021 May 29. pii: 10.1007/s00296-021-04893.
    PubMed     Abstract available


  14. SOYSAL E, Ulutas F, Tepeli E, Kaymaz S, et al
    IL-23R gene polymorphisms in rheumatoid arthritis.
    Rheumatol Int. 2021 May 12. pii: 10.1007/s00296-021-04881.
    PubMed     Abstract available


  15. BHATIA A, Kc M, Gupta L
    Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions.
    Rheumatol Int. 2021;41:843-850.
    PubMed     Abstract available


  16. MIGKOS MP, Kaltsonoudis E, Pelechas E, Drossou V, et al
    Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.
    Rheumatol Int. 2021;41:903-909.
    PubMed     Abstract available


    April 2021
  17. KAESTNER S, Wolff HJ, Braeuer R, Kaestner P, et al
    Immunoglobulin deficiencies in treated patients suffering from rheumatoid arthritis.
    Rheumatol Int. 2021 Apr 29. pii: 10.1007/s00296-021-04871.
    PubMed     Abstract available


  18. MAEDA Y, Hirano T, Ebina K, Hara R, et al
    Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.
    Rheumatol Int. 2021 Apr 26. pii: 10.1007/s00296-021-04862.
    PubMed     Abstract available


  19. TONGA E, Williamson E, Srikesavan C, Ozen T, et al
    A hand exercise mobile app for people with rheumatoid arthritis in Turkey: design, development and usability study.
    Rheumatol Int. 2021 Apr 18. pii: 10.1007/s00296-021-04860.
    PubMed     Abstract available


  20. LU H, Yao Y, Yang J, Zhang H, et al
    Microbiome-miRNA interactions in the progress from undifferentiated arthritis to rheumatoid arthritis: evidence, hypotheses, and opportunities.
    Rheumatol Int. 2021 Apr 15. pii: 10.1007/s00296-021-04798.
    PubMed     Abstract available


  21. CHELLAMUTHU G, Muthu S, Khanna M, Khanna V, et al
    "Platelet-rich plasma holds promise in management of rheumatoid arthritis"-systematic review.
    Rheumatol Int. 2021 Apr 8. pii: 10.1007/s00296-021-04849.
    PubMed     Abstract available


    March 2021
  22. CRONIN O, McKnight O, Keir L, Ralston SH, et al
    A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
    Rheumatol Int. 2021 Mar 15. pii: 10.1007/s00296-021-04835.
    PubMed     Abstract available


  23. YILDIRIM R, Cansu DU, Arik D, Saylisoy S, et al
    Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review.
    Rheumatol Int. 2021 Mar 9. pii: 10.1007/s00296-021-04822.
    PubMed     Abstract available


    February 2021
  24. PELECHAS E, Voulgari PV, Drosos AA
    Insulin resistance in patients with rheumatoid arthritis.
    Rheumatol Int. 2021 Feb 26. pii: 10.1007/s00296-021-04814.
    PubMed    


  25. ALMUTAIRI K, Inderjeeth C, Preen DB, Keen H, et al
    The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia.
    Rheumatol Int. 2021 Feb 23. pii: 10.1007/s00296-021-04811.
    PubMed     Abstract available


  26. FEUCHTENBERGER M, Kraus L, Nigg A, Schulze-Koops H, et al
    Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study).
    Rheumatol Int. 2021 Feb 20. pii: 10.1007/s00296-021-04804.
    PubMed     Abstract available


  27. VAJDIC ID, Stimac G, Pezelj I, Mustapic M, et al
    Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2021 Feb 12. pii: 10.1007/s00296-021-04800.
    PubMed     Abstract available


  28. ZIADE N, Saad S, Al Mashaleh M, El Kibbi L, et al
    Perceptions of patients with rheumatoid arthritis about self-assessment of disease activity after watching an educational video: a qualitative pilot study from the AUTO-DAS in Middle Eastern Arab countries project.
    Rheumatol Int. 2021 Feb 6. pii: 10.1007/s00296-021-04799.
    PubMed     Abstract available


    January 2021
  29. MATHIEU S, Pereira B, Saraux A, Richez C, et al
    Disease-modifying drug retention rate according to patient age in patients with early rheumatoid arthritis: analysis of the ESPOIR cohort.
    Rheumatol Int. 2021 Jan 12. pii: 10.1007/s00296-020-04770.
    PubMed     Abstract available


  30. GUTIERREZ J, Sandoval H, Perez-Neri I, Arauz A, et al
    Advances in imaging technologies for the assessment of peripheral neuropathies in rheumatoid arthritis.
    Rheumatol Int. 2021 Jan 11. pii: 10.1007/s00296-020-04780.
    PubMed     Abstract available


  31. MCKENNA SG, Donnelly A, Esbensen BA, Comber L, et al
    The feasibility of an exercise intervention to improve sleep (time, quality and disturbance) in people with rheumatoid arthritis: a pilot RCT.
    Rheumatol Int. 2021 Jan 2. pii: 10.1007/s00296-020-04760.
    PubMed     Abstract available


  32. FELLOUS S, Rkain H, Ahid S, Abouqal R, et al
    One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry.
    Rheumatol Int. 2021 Jan 2. pii: 10.1007/s00296-020-04762.
    PubMed     Abstract available


  33. MASIC D, Stengaard-Pedersen K, Logstrup BB, Horslev-Petersen K, et al
    Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial.
    Rheumatol Int. 2021 Jan 2. pii: 10.1007/s00296-020-04756.
    PubMed     Abstract available


  34. GIARDINA F, Izzo R, Gattamelata A, Colafrancesco S, et al
    COVID-19 in Italian Sjogren's syndrome patients: a monocentric study.
    Rheumatol Int. 2021;41:235-236.
    PubMed    


    December 2020
  35. GORODETSKIY VR, Sidorova YV, Kupryshina NA, Vasilyev VI, et al
    Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis.
    Rheumatol Int. 2020 Dec 5. pii: 10.1007/s00296-020-04757.
    PubMed     Abstract available


  36. LOARCE-MARTOS J, Garcia-Fernandez A, Lopez-Gutierrez F, Garcia-Garcia V, et al
    High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
    Rheumatol Int. 2020;40:2015-2021.
    PubMed     Abstract available


    November 2020
  37. BRADY SM, Fenton SAM, Metsios GS, Bosworth A, et al
    Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19.
    Rheumatol Int. 2020 Nov 30. pii: 10.1007/s00296-020-04751.
    PubMed     Abstract available


  38. PAPPAS DA, Brittle C, Mossell JE 3rd, Withers JB, et al
    Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study.
    Rheumatol Int. 2020 Nov 30. pii: 10.1007/s00296-020-04746.
    PubMed     Abstract available


  39. PELECHAS E, Voulgari PV, Drosos AA
    Occupational mimics of rheumatoid arthritis: hair dye-induced arthritis.
    Rheumatol Int. 2020 Nov 16. pii: 10.1007/s00296-020-04748.
    PubMed     Abstract available


  40. KAYA SUBASI P, Guler T, Yurdakul FG, Ataman S, et al
    Carpal tunnel syndrome in patients with rheumatoid arthritis and psoriatic arthritis: an electrophysiological and ultrasonographic study.
    Rheumatol Int. 2020 Nov 13. pii: 10.1007/s00296-020-04745.
    PubMed     Abstract available


  41. ALMUTAIRI K, Nossent J, Preen D, Keen H, et al
    The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review.
    Rheumatol Int. 2020 Nov 11. pii: 10.1007/s00296-020-04731.
    PubMed     Abstract available


  42. ABUALFADL E, Ismail F, Shereef RRE, Hassan E, et al
    Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient.
    Rheumatol Int. 2020 Nov 1. pii: 10.1007/s00296-020-04736.
    PubMed     Abstract available


    October 2020
  43. ORTIZ AM, Silva Fernandez L, Villaverde V, Abad MA, et al
    Gaps between research and recommendations in rheumatoid arthritis.
    Rheumatol Int. 2020 Oct 20. pii: 10.1007/s00296-020-04724.
    PubMed     Abstract available


  44. LINDNER L, Callhoff J, Alten R, Krause A, et al
    Correction to: Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017.
    Rheumatol Int. 2020 Oct 16. pii: 10.1007/s00296-020-04725.
    PubMed     Abstract available


  45. LIFF MH, Hoff M, Wisloff U, Videm V, et al
    Faster age-related decline in cardiorespiratory fitness in rheumatoid arthritis patients: an observational study in the Trondelag Health Study.
    Rheumatol Int. 2020 Oct 9. pii: 10.1007/s00296-020-04713.
    PubMed     Abstract available


  46. MONTERO F, Martinez-Barrio J, Serrano-Benavente B, Gonzalez T, et al
    Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Rheumatol Int. 2020;40:1593-1598.
    PubMed     Abstract available


  47. SZEWCZYK D, Sadura-Sieklucka T, Sokolowska B, Ksiezopolska-Orlowska K, et al
    Improving the quality of life of patients with rheumatoid arthritis after rehabilitation irrespective of the level of disease activity.
    Rheumatol Int. 2020 Oct 1. pii: 10.1007/s00296-020-04711.
    PubMed     Abstract available


  48. BARESIC M, Jezic I, Simetic L, Herceg D, et al
    Rituximab as a treatment option in a patient with rheumatoid arthritis and a history of malignancy-intracranial chondrosarcoma/osteochondroma-case based review.
    Rheumatol Int. 2020 Oct 1. pii: 10.1007/s00296-020-04706.
    PubMed     Abstract available


    September 2020
  49. NAGAI Y, Yokogawa N, Shimada K, Sugii S, et al
    Utility of the neutrophil-to-lymphocyte ratio for predicting bacterial infection in patients with rheumatoid arthritis receiving Tocilizumab.
    Rheumatol Int. 2020 Sep 23. pii: 10.1007/s00296-020-04705.
    PubMed     Abstract available


  50. PAPPAS DA, Litman HJ, Lesperance T, Kricorian G, et al
    Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data.
    Rheumatol Int. 2020 Sep 2. pii: 10.1007/s00296-020-04667.
    PubMed     Abstract available


    August 2020
  51. DAVERGNE T, Moe RH, Fautrel B, Gossec L, et al
    Development and initial validation of a questionnaire to assess facilitators and barriers to physical activity for patients with rheumatoid arthritis, axial spondyloarthritis and/or psoriatic arthritis.
    Rheumatol Int. 2020 Aug 30. pii: 10.1007/s00296-020-04692.
    PubMed     Abstract available


  52. JAMTHIKAR AD, Gupta D, Puvvula A, Johri AM, et al
    Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging.
    Rheumatol Int. 2020 Aug 28. pii: 10.1007/s00296-020-04691.
    PubMed     Abstract available


  53. UTHMAN I, Almoallim H, Buckley CD, Masri B, et al
    Nurse-led care for the management of rheumatoid arthritis: a review of the global literature and proposed strategies for implementation in Africa and the Middle East.
    Rheumatol Int. 2020 Aug 26. pii: 10.1007/s00296-020-04682.
    PubMed     Abstract available


  54. PENCHEVA DT, Heaney A, McKenna SP, Monov SV, et al
    Adaptation and validation of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire for use in Bulgaria.
    Rheumatol Int. 2020 Aug 19. pii: 10.1007/s00296-020-04686.
    PubMed     Abstract available


  55. REMALANTE PPM, Salido EO, Penserga EG, Gauiran DTV, et al
    Red cell distribution width and neutrophil-lymphocyte ratio in rheumatoid arthritis.
    Rheumatol Int. 2020 Aug 19. pii: 10.1007/s00296-020-04685.
    PubMed     Abstract available


  56. VAN DEN OEVER IAM, Baniaamam M, Simsek S, Raterman HG, et al
    The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis.
    Rheumatol Int. 2020 Aug 10. pii: 10.1007/s00296-020-04666.
    PubMed     Abstract available


  57. DIMITROULAS T, Baniotopoulos P, Pagkopoulou E, Soulaidopoulos S, et al
    Subclinical atherosclerosis in systemic sclerosis and rheumatoid arthritis: a comparative matched-cohort study.
    Rheumatol Int. 2020 Aug 8. pii: 10.1007/s00296-020-04677.
    PubMed     Abstract available


    July 2020
  58. HAMMOND A, Meesters J, Niedermann K, Tennant A, et al
    Cross-cultural adaptation and psychometric testing of the Dutch and German versions of the Evaluation of Daily Activity Questionnaire in people with rheumatoid arthritis.
    Rheumatol Int. 2020 Jul 26. pii: 10.1007/s00296-020-04657.
    PubMed     Abstract available


  59. VASCONCELOS LB, Silva MT, Galvao TF
    Reduction of biologics in rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2020 Jul 24. pii: 10.1007/s00296-020-04651.
    PubMed     Abstract available


  60. KRIL I, Havrylyuk A, Potomkina H, Chopyak V, et al
    Apoptosis and secondary necrosis of neutrophils and monocytes in the immunopathogenesis of rheumatoid arthritis: a cohort study.
    Rheumatol Int. 2020 Jul 10. pii: 10.1007/s00296-020-04642.
    PubMed     Abstract available


  61. ELGHAWY AA, Skopis M, Davis J, Bag-Ozbek A, et al
    Angiostrongyliasis infection masquerading as granulomatosis with polyangiitis: a case-based review.
    Rheumatol Int. 2020;40:1171-1176.
    PubMed     Abstract available


  62. LI R, Wan Q, Chen P, Mao S, et al
    Tocilizumab treatment in Felty's syndrome.
    Rheumatol Int. 2020;40:1143-1149.
    PubMed     Abstract available


  63. LEE SB, Choi H, Kim MK, Jung SM, et al
    Can antineutrophil cytoplasmic antibody positivity at diagnosis predict the poor outcomes of Sjogren's syndrome?
    Rheumatol Int. 2020;40:1063-1070.
    PubMed     Abstract available


    June 2020
  64. WESTHOVENS R, Connolly SE, Margaux J, Vanden Berghe M, et al
    Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study.
    Rheumatol Int. 2020 Jun 17. pii: 10.1007/s00296-020-04619.
    PubMed     Abstract available


  65. VENETSANOPOULOU AI, Pelechas E, Voulgari PV, Drosos AA, et al
    The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk.
    Rheumatol Int. 2020 Jun 10. pii: 10.1007/s00296-020-04616.
    PubMed     Abstract available


  66. CHAITIDIS N, Theocharis P, Festas C, Aritzi I, et al
    Association of rheumatoid arthritis with hearing loss: a systematic review and meta-analysis.
    Rheumatol Int. 2020 Jun 2. pii: 10.1007/s00296-020-04609.
    PubMed     Abstract available


  67. SAPUNDZHIEVA T, Karalilova R, Batalov A
    Hand ultrasound patterns in rheumatoid and psoriatic arthritis: the role of ultrasound in the differential diagnosis.
    Rheumatol Int. 2020;40:837-848.
    PubMed     Abstract available


    May 2020
  68. O'BRIEN CM, Duda JL, Kitas GD, Veldhuijzen van Zanten JJCS, et al
    Measurement of sedentary time and physical activity in rheumatoid arthritis: an ActiGraph and activPAL validation study.
    Rheumatol Int. 2020 May 29. pii: 10.1007/s00296-020-04608.
    PubMed     Abstract available


  69. MARTINEZ G, Feist E, Martiatu M, Garay H, et al
    Autoantibodies against a novel citrullinated fibrinogen peptide related to smoking status, disease activity and therapeutic response to methotrexate in cuban patients with early rheumatoid arthritis.
    Rheumatol Int. 2020 May 29. pii: 10.1007/s00296-020-04580.
    PubMed     Abstract available


  70. HARROLD LR, Shan Y, Rebello S, Kramer N, et al
    Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjogren's syndrome enrolled in a large observational US registry.
    Rheumatol Int. 2020 May 24. pii: 10.1007/s00296-020-04602.
    PubMed     Abstract available


  71. LINDNER L, Callhoff J, Alten R, Krause A, et al
    Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017.
    Rheumatol Int. 2020 May 6. pii: 10.1007/s00296-020-04593.
    PubMed     Abstract available


  72. GEORGIEV T
    Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.
    Rheumatol Int. 2020;40:825-826.
    PubMed    


  73. PARK EH, Lee EY, Shin K, Kim HA, et al
    Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
    Rheumatol Int. 2020;40:791-798.
    PubMed     Abstract available


    April 2020
  74. CHUNG TT, Ko HJ, Lau CS, Chung HY, et al
    A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis.
    Rheumatol Int. 2020 Apr 21. pii: 10.1007/s00296-020-04583.
    PubMed     Abstract available


  75. SONG J, Kang S, Choi SW, Seo KW, et al
    Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs.
    Rheumatol Int. 2020 Apr 20. pii: 10.1007/s00296-020-04584.
    PubMed     Abstract available


  76. AYAN G, Esatoglu SN, Hatemi G, Hamuryudan V, et al
    Disease course and healthcare costs of a cohort of rheumatoid arthritis patients from Turkey.
    Rheumatol Int. 2020 Apr 6. pii: 10.1007/s00296-020-04574.
    PubMed     Abstract available


  77. OLAH C, Kardos Z, Kostyal L, Hodosi K, et al
    Correction to: Assessment of cervical spine involvement in rheumatoid arthritis patients in the era of biologics: a real-life, cross-sectional MRI study.
    Rheumatol Int. 2020 Apr 4. pii: 10.1007/s00296-020-04572.
    PubMed     Abstract available


  78. BENSON R, Zhao SS, Goodson N, Abernethy R, et al
    Correction to: Biologic monotherapy in the biologic naive patient with rheumatoid arthritis (RA): results from an observational study.
    Rheumatol Int. 2020 Apr 2. pii: 10.1007/s00296-020-04556.
    PubMed     Abstract available


  79. MASLINSKA M, Wojciechowska B, Manczak M, Kwiatkowska B, et al
    Serum immunoglobulin G4 in Sjogren's syndrome: a pilot study.
    Rheumatol Int. 2020;40:555-561.
    PubMed     Abstract available


  80. TRAIANOS EY, Locke J, Lendrem D, Bowman S, et al
    Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjogren's syndrome.
    Rheumatol Int. 2020;40:541-548.
    PubMed     Abstract available


    March 2020
  81. CSABA O, Kardos Z, Kostyal L, Hodosi K, et al
    Assessment of cervical spine involvement in rheumatoid arthritis patients in the era of biologics: a real-life, cross-sectional MRI study.
    Rheumatol Int. 2020 Mar 16. pii: 10.1007/s00296-020-04549.
    PubMed     Abstract available


  82. LEE JS, Oh JS, Kim YG, Lee CK, et al
    Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction.
    Rheumatol Int. 2020 Mar 13. pii: 10.1007/s00296-020-04547.
    PubMed     Abstract available


  83. SEBASTIAN A, Madej M, Sebastian M, Butrym A, et al
    Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjogren's syndrome.
    Rheumatol Int. 2020;40:399-404.
    PubMed     Abstract available


  84. KIM HW, Kwon OC, Han SH, Park MC, et al
    Positive conversion of interferon-gamma release assay in patients with rheumatic diseases treated with biologics.
    Rheumatol Int. 2020;40:471-479.
    PubMed     Abstract available


  85. GORODETSKIY VR, Probatova NA, Radenska-Lopovok SG, Ryzhikova NV, et al
    Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren's syndrome patients: case series study and review of the literature.
    Rheumatol Int. 2020;40:499-506.
    PubMed     Abstract available


    February 2020
  86. WEIJERS JM, Semb AG, Rollefstad S, Kitas GD, et al
    Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers.
    Rheumatol Int. 2020 Feb 22. pii: 10.1007/s00296-020-04533.
    PubMed     Abstract available


  87. BENSON R, Zhao SS, Goodson N, Abernethy R, et al
    Biologic monotherapy in the biologic naive patient with rheumatoid arthritis (RA): results from an observational study.
    Rheumatol Int. 2020 Feb 21. pii: 10.1007/s00296-020-04531.
    PubMed     Abstract available


  88. PFLUGBEIL S, Bockl K, Pongratz R, Leitner M, et al
    Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis.
    Rheumatol Int. 2020 Feb 12. pii: 10.1007/s00296-020-04526.
    PubMed     Abstract available


  89. KOEHM M, McIntosh MJ, Hofmann MW, Abraham V, et al
    Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies.
    Rheumatol Int. 2020 Feb 10. pii: 10.1007/s00296-020-04514.
    PubMed     Abstract available


  90. CHUNG SW, Park EH, Kang EH, Lee YJ, et al
    Diffuse large B-cell lymphoma involving the left sternoclavicular joint mimicking rheumatoid arthritis flare: a case-based review.
    Rheumatol Int. 2020 Feb 8. pii: 10.1007/s00296-020-04528.
    PubMed     Abstract available


  91. ZAICHKO K, Stanislavchuk M, Zaichko N
    Circadian fluctuations of endothelial nitric oxide synthase activity in females with rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2020 Feb 5. pii: 10.1007/s00296-020-04525.
    PubMed     Abstract available


  92. BERNARDINO V, Rodrigues A, Llado A, Panarra A, et al
    Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic.
    Rheumatol Int. 2020;40:295-301.
    PubMed     Abstract available


  93. CARANDANG K, Vigen CLP, Ortiz E, Pyatak EA, et al
    Re-conceptualizing functional status through experiences of young adults with inflammatory arthritis.
    Rheumatol Int. 2020;40:273-282.
    PubMed     Abstract available


    January 2020
  94. SZEKANECZ Z
    Reply to: Comment on "effects of 1-year anti-TNF-alpha therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis" by Cure et al.
    Rheumatol Int. 2020 Jan 30. pii: 10.1007/s00296-020-04521.
    PubMed    


  95. CURE E, Cumhur Cure M
    Comment on "Effects of 1-year anti-TNF-alpha therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis".
    Rheumatol Int. 2020 Jan 18. pii: 10.1007/s00296-020-04513.
    PubMed    


  96. XU S, Liang Y, Meng F, Zhu Z, et al
    Risk prediction of degenerative scoliosis combined with lumbar spinal stenosis in patients with rheumatoid arthritis: a case-control study.
    Rheumatol Int. 2020 Jan 9. pii: 10.1007/s00296-019-04508.
    PubMed     Abstract available


  97. DAVIDA L, Pongracz V, Mohamed EA, Szamosi S, et al
    Correction to: A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis.
    Rheumatol Int. 2020 Jan 6. pii: 10.1007/s00296-019-04509.
    PubMed     Abstract available


  98. GODA K, Kenzaka T, Hoshijima M, Yachie A, et al
    Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.
    Rheumatol Int. 2020;40:145-152.
    PubMed     Abstract available


  99. RUSCITTI P, Cipriani P, Liakouli V, Iacono D, et al
    Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
    Rheumatol Int. 2020;40:107-113.
    PubMed     Abstract available


    December 2019
  100. DAVIDA L, Pongracz V, Mohamed EA, Szamosi S, et al
    A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis.
    Rheumatol Int. 2019 Dec 19. pii: 10.1007/s00296-019-04503.
    PubMed     Abstract available


  101. VEGH E, Kerekes G, Pusztai A, Hamar A, et al
    Effects of 1-year anti-TNF-alpha therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.
    Rheumatol Int. 2019 Dec 17. pii: 10.1007/s00296-019-04497.
    PubMed     Abstract available


  102. GROSSE J, Allado E, Roux C, Pierreisnard A, et al
    ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography.
    Rheumatol Int. 2019 Dec 13. pii: 10.1007/s00296-019-04492.
    PubMed     Abstract available


  103. METSIOS GS, Moe RH, van der Esch M, van Zanten JJCSV, et al
    The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis.
    Rheumatol Int. 2019 Dec 4. pii: 10.1007/s00296-019-04483.
    PubMed     Abstract available


    November 2019
  104. BIALOWAS K, Radwan-Oczko M, Dus-Ilnicka I, Korman L, et al
    Periodontal disease and influence of periodontal treatment on disease activity in patients with rheumatoid arthritis and spondyloarthritis.
    Rheumatol Int. 2019 Nov 7. pii: 10.1007/s00296-019-04460.
    PubMed     Abstract available


    October 2019
  105. MURATA K, Hashimoto M, Yamamoto W, Son Y, et al
    The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER co
    Rheumatol Int. 2019 Oct 16. pii: 10.1007/s00296-019-04464.
    PubMed     Abstract available


  106. CONTRERAS-YANEZ I, Guaracha-Basanez G, Pascual-Ramos V
    Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study.
    Rheumatol Int. 2019 Oct 12. pii: 10.1007/s00296-019-04451.
    PubMed     Abstract available


  107. BROM M, Moyano S, Gandino IJ, Scolnik M, et al
    Incidence of cancer in a cohort of patients with primary Sjogren syndrome in Argentina.
    Rheumatol Int. 2019;39:1697-1702.
    PubMed     Abstract available


    September 2019
  108. OLAH C, Kardos Z, Andrejkovics M, Szarka E, et al
    Assessment of cognitive function in female rheumatoid arthritis patients: associations with cerebrovascular pathology, depression and anxiety.
    Rheumatol Int. 2019 Sep 25. pii: 10.1007/s00296-019-04449.
    PubMed     Abstract available


  109. GONZALEZ-CHAVEZ SA, Pacheco-Tena C, de Jesus Caraveo-Frescas T, Quinonez-Flores CM, et al
    Oral health and orofacial function in patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Sep 17. pii: 10.1007/s00296-019-04440.
    PubMed     Abstract available


  110. RYDHOLM M, Wikstrom I, Hagel S, Jacobsson LTH, et al
    The relation between upper extremity joint involvement and grip force in early rheumatoid arthritis: a retrospective study.
    Rheumatol Int. 2019 Sep 7. pii: 10.1007/s00296-019-04438.
    PubMed     Abstract available


  111. COONEY JK, Ahmad YA, Moore JP, Sandoo A, et al
    The impact of cardiorespiratory fitness on classical cardiovascular disease risk factors in rheumatoid arthritis: a cross-sectional and longitudinal study.
    Rheumatol Int. 2019 Sep 3. pii: 10.1007/s00296-019-04431.
    PubMed     Abstract available


  112. WEI Z, Jiaying S, Junhong G
    Bilateral facial paralysis as a rare neurological manifestation of primary Sjogren's syndrome: case-based review.
    Rheumatol Int. 2019;39:1651-1654.
    PubMed     Abstract available


  113. OLSSON P, Bodewes ILA, Nilsson AM, Turesson C, et al
    Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjogren's syndrome.
    Rheumatol Int. 2019;39:1575-1584.
    PubMed     Abstract available


  114. OKU K, Atsumi T
    Rheumatology practice in Japan: challenges and opportunities.
    Rheumatol Int. 2019;39:1499-1505.
    PubMed     Abstract available


    August 2019
  115. KLIMENTA B, Nefic H, Prodanovic N, Jadric R, et al
    Association of biomarkers of inflammation and HLA-DRB1 gene locus with risk of developing rheumatoid arthritis in females.
    Rheumatol Int. 2019 Aug 26. pii: 10.1007/s00296-019-04429.
    PubMed     Abstract available


  116. FAVALLI EG, Becciolini A, Carletto A, Conti F, et al
    Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort.
    Rheumatol Int. 2019 Aug 21. pii: 10.1007/s00296-019-04416.
    PubMed     Abstract available


  117. GO DJ, Lee SJ, Joo SH, Cheon GJ, et al
    Potential clinical utility of a novel optical tomographic imaging for the quantitative assessment of hand rheumatoid arthritis.
    Rheumatol Int. 2019 Aug 21. pii: 10.1007/s00296-019-04424.
    PubMed     Abstract available


  118. ULUTATAR F, Unal-Ulutatar C, Duruoz MT
    Cervical proprioceptive impairment in patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Aug 21. pii: 10.1007/s00296-019-04419.
    PubMed     Abstract available


  119. LEE JS, Lim DH, Oh JS, Kim YG, et al
    Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study.
    Rheumatol Int. 2019 Aug 14. pii: 10.1007/s00296-019-04418.
    PubMed     Abstract available


  120. DE AGUSTIN JJ, Erra A, Ponce A, Moragues C, et al
    Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation.
    Rheumatol Int. 2019 Aug 8. pii: 10.1007/s00296-019-04383.
    PubMed     Abstract available


  121. GOMEZ-CENTENO A, Rubio-Romero E, Ovalles JG, Manrique-Arija S, et al
    Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study.
    Rheumatol Int. 2019 Aug 8. pii: 10.1007/s00296-019-04378.
    PubMed     Abstract available


  122. SHRESHER NM, Mohamed AE, Elshahaly MH
    Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Aug 3. pii: 10.1007/s00296-019-04403.
    PubMed     Abstract available


  123. YANG Y, Wang Z, Fu Z, Yang R, et al
    Stiffening of aorta is more preferentially associated with rheumatoid arthritis than peripheral arteries.
    Rheumatol Int. 2019 Aug 2. pii: 10.1007/s00296-019-04405.
    PubMed     Abstract available


    July 2019
  124. COFFEY CM, Davis JM 3rd, Crowson CS
    The impact of gender on time to rheumatoid arthritis classification: a retrospective analysis of a population-based cohort.
    Rheumatol Int. 2019 Jul 23. pii: 10.1007/s00296-019-04360.
    PubMed     Abstract available


  125. KUCHARSKI D, Lange E, Ross AB, Svedlund S, et al
    Moderate-to-high intensity exercise with person-centered guidance influences fatigue in older adults with rheumatoid arthritis.
    Rheumatol Int. 2019 Jul 20. pii: 10.1007/s00296-019-04384.
    PubMed     Abstract available


  126. ALHAJERI H, Abutiban F, Al-Adsani W, Al-Awadhi A, et al
    Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Jul 15. pii: 10.1007/s00296-019-04372.
    PubMed     Abstract available


  127. POPOVA V, Vazhev Z, Geneva-Popova M, Batalov A, et al
    Comparison of RANKL expression, inflammatory markers, and cardiovascular risk in patients with acute coronary syndrome with and without rheumatoid arthritis.
    Rheumatol Int. 2019 Jul 11. pii: 10.1007/s00296-019-04367.
    PubMed     Abstract available


  128. LILA AM, Mazurov VI, Denisov LN, Nesmeyanova OB, et al
    A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study.
    Rheumatol Int. 2019 Jul 10. pii: 10.1007/s00296-019-04359.
    PubMed     Abstract available


    June 2019
  129. FOO J, Morel C, Bergman M, Baerwald C, et al
    Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada.
    Rheumatol Int. 2019 Jun 25. pii: 10.1007/s00296-019-04352.
    PubMed     Abstract available


  130. SINGH A, Misra R, Aggarwal A
    Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Jun 15. pii: 10.1007/s00296-019-04344.
    PubMed     Abstract available


  131. MICHAEL BNR, Kommoju V, Kavadichanda Ganapathy C, Negi VS, et al
    Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Jun 14. pii: 10.1007/s00296-019-04337.
    PubMed     Abstract available


  132. WU GC, Tao SS, Zhao CN, Mao YM, et al
    Correction: Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis.
    Rheumatol Int. 2019 Jun 6. pii: 10.1007/s00296-019-04342.
    PubMed    


  133. OTON T, Carmona L, Urruticoechea-Arana A, Calvo-Alen J, et al
    Discordance between doctor and patient assessments and non-adherence to subcutaneous biological drugs.
    Rheumatol Int. 2019;39:1077-1082.
    PubMed     Abstract available


  134. VIKSE J, Jonsdottir K, Kvaloy JT, Wildhagen K, et al
    Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseases.
    Rheumatol Int. 2019;39:1083-1090.
    PubMed     Abstract available


  135. ROSAS J, Sanchez-Piedra C, Fernandez-Castro M, Andreu JL, et al
    ESSDAI activity index of the SJOGRENSER cohort: analysis and comparison with other European cohorts.
    Rheumatol Int. 2019;39:991-999.
    PubMed     Abstract available


  136. GADEHOLT O, Feuchtenberger M, Wech T, Schwaneck EC, et al
    Power-Doppler perfusion phenotype in RA patients is dependent on anti-citrullinated peptide antibody status, not on rheumatoid factor.
    Rheumatol Int. 2019;39:1019-1025.
    PubMed     Abstract available


    May 2019
  137. DROSOS AA, Pelechas E, Voulgari PV
    Conventional radiography of the hands and wrists in rheumatoid arthritis. What a rheumatologist should know and how to interpret the radiological findings.
    Rheumatol Int. 2019 May 22. pii: 10.1007/s00296-019-04326.
    PubMed     Abstract available


  138. FUJIMORI M, Kamishima T, Narita A, Henmi M, et al
    Quantitative power Doppler signal assessment in the subchondral bone region of the metacarpophalangeal joint is an effective predictor of radiographic progression in the hand of rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2019 May 14. pii: 10.1007/s00296-019-04320.
    PubMed     Abstract available


  139. NOVIKOVA DS, Udachkina HV, Markelova EI, Kirillova IG, et al
    Dynamics of body mass index and visceral adiposity index in patients with rheumatoid arthritis treated with tofacitinib.
    Rheumatol Int. 2019 May 3. pii: 10.1007/s00296-019-04303.
    PubMed     Abstract available


    April 2019
  140. YANG JH, Kwon HH, Lee JK, Bang SY, et al
    Successful arthroscopic treatment of refractory and complicated popliteal cyst associated with rheumatoid arthritis in combination with osteoarthritis: case series and literature review.
    Rheumatol Int. 2019 Apr 11. pii: 10.1007/s00296-019-04278.
    PubMed     Abstract available


  141. WU GC, Tao SS, Zhao CN, Mao YM, et al
    Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis.
    Rheumatol Int. 2019 Apr 6. pii: 10.1007/s00296-019-04297.
    PubMed     Abstract available


  142. VASILEV G, Ivanova M, Ivanova-Todorova E, Tumangelova-Yuzeir K, et al
    Secretory factors produced by adipose mesenchymal stem cells downregulate Th17 and increase Treg cells in peripheral blood mononuclear cells from rheumatoid arthritis patients.
    Rheumatol Int. 2019 Apr 3. pii: 10.1007/s00296-019-04296.
    PubMed     Abstract available


  143. FARA N, Recchia O, Sequeira G, Sanchez K, et al
    Disability due to rheumatic diseases in the city of Junin, Argentina.
    Rheumatol Int. 2019;39:729-733.
    PubMed     Abstract available


  144. NISAR MK
    Early arthritis clinic is effective for rheumatoid and psoriatic arthritides.
    Rheumatol Int. 2019;39:657-662.
    PubMed     Abstract available


    March 2019
  145. BURGHARDT RD, Kazim MA, Ruther W, Niemeier A, et al
    The impact of physical activity on serum levels of inflammatory markers in rheumatoid arthritis: a systematic literature review.
    Rheumatol Int. 2019 Mar 21. pii: 10.1007/s00296-019-04284.
    PubMed     Abstract available


  146. LEE HN, Kim YK, Kim GT, Ahn E, et al
    Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-alpha agents in patients with rheumatoid arthritis: a retrospective chart review analysis.
    Rheumatol Int. 2019 Mar 14. pii: 10.1007/s00296-019-04276.
    PubMed     Abstract available


  147. UNAL O, Can ME, Ozcan A, Ozcan ME, et al
    Color Doppler imaging of ocular hemodynamic changes in patients with rheumatoid arthritis unrelated to disease activity.
    Rheumatol Int. 2019 Mar 12. pii: 10.1007/s00296-019-04275.
    PubMed     Abstract available


  148. QOROLLI M, Rexhepi B, Rexhepi S, Mustapic M, et al
    Association between disease activity measured by RAPID3 and health-related quality of life in patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Mar 7. pii: 10.1007/s00296-019-04258.
    PubMed     Abstract available


  149. CHANDRASHEKARA S, Shobha V, Rao V, Desai A, et al
    Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India.
    Rheumatol Int. 2019;39:497-507.
    PubMed     Abstract available


  150. JACOB L, Chevalier T, Kostev K
    Persistence with biological drugs in patients treated in rheumatology practices in Germany.
    Rheumatol Int. 2019;39:525-531.
    PubMed     Abstract available


  151. GEORGIEV T, Stoilov R
    Bulgarian rheumatology: science and practice in a cost-constrained environment.
    Rheumatol Int. 2019;39:417-429.
    PubMed     Abstract available


  152. HERNANDEZ MV, Sanchez-Piedra C, Garcia-Magallon B, Cuende E, et al
    Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry.
    Rheumatol Int. 2019;39:509-515.
    PubMed     Abstract available


    February 2019
  153. DOKO I, Bajic Z, Dubravic A, Qorolli M, et al
    Hand grip endurance moderating the effect of grip force on functional ability and disease activity in rheumatoid arthritis patients: a cross-sectional study.
    Rheumatol Int. 2019 Feb 12. pii: 10.1007/s00296-019-04250.
    PubMed     Abstract available


  154. BYKERK VP, Burmester GR, Combe BG, Furst DE, et al
    Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.
    Rheumatol Int. 2019 Feb 5. pii: 10.1007/s00296-018-4232.
    PubMed     Abstract available


  155. MIYAMOTO ST, Valim V, Carletti L, Ng WF, et al
    Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjogren's syndrome: a randomized-controlled trial.
    Rheumatol Int. 2019;39:227-238.
    PubMed     Abstract available


    January 2019
  156. KAWATKAR AA, Gabriel SE, Jacobsen SJ
    Secular trends in the incidence and prevalence of rheumatoid arthritis within members of an integrated health care delivery system.
    Rheumatol Int. 2019 Jan 17. pii: 10.1007/s00296-018-04235.
    PubMed     Abstract available


  157. TADA Y, Inokuchi S, Maruyama A, Suematsu R, et al
    Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
    Rheumatol Int. 2019;39:97-104.
    PubMed     Abstract available


    December 2018
  158. PFEIL A, Nussbaum A, Renz DM, Jung C, et al
    Inhibition of periarticular bone loss is associated with clinical remission and ACR70-Response in rheumatoid arthritis.
    Rheumatol Int. 2018 Dec 19. pii: 10.1007/s00296-018-4226.
    PubMed     Abstract available


  159. PELECHAS E, Papoudou-Bai A, Voulgari PV, Drosos AA, et al
    Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review.
    Rheumatol Int. 2018 Dec 7. pii: 10.1007/s00296-018-4212.
    PubMed     Abstract available


  160. SALAFFI F, Di Carlo M, Carotti M, Farah S, et al
    Validity and interpretability of the QuickDASH in the assessment of hand disability in rheumatoid arthritis.
    Rheumatol Int. 2018 Dec 3. pii: 10.1007/s00296-018-4216.
    PubMed     Abstract available


    November 2018
  161. TORRENTE-SEGARRA V, Fernandez Prada M, Exposito Moliner R, Garrido Punal NP, et al
    How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol.
    Rheumatol Int. 2018 Nov 24. pii: 10.1007/s00296-018-4205.
    PubMed    


  162. EMMANUEL D, Parija SC, Jain A, Misra DP, et al
    Persistent eosinophilia in rheumatoid arthritis: a prospective observational study.
    Rheumatol Int. 2018 Nov 13. pii: 10.1007/s00296-018-4191.
    PubMed     Abstract available


  163. VELDHUIJZEN VAN ZANTEN JJCS, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, et al
    Comparison of the effects of exercise and anti-TNF treatment on cardiovascular health in rheumatoid arthritis: results from two controlled trials.
    Rheumatol Int. 2018 Nov 12. pii: 10.1007/s00296-018-4183.
    PubMed     Abstract available


  164. KRUGER K, Burmester GR, Wassenberg S, Bohl-Buhler M, et al
    Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany.
    Rheumatol Int. 2018 Nov 10. pii: 10.1007/s00296-018-4180.
    PubMed     Abstract available


  165. GENERALI E, Carrara G, Kallikourdis M, Condorelli G, et al
    Risk of hospitalization for heart failure in rheumatoid arthritis patients treated with etanercept and abatacept.
    Rheumatol Int. 2018 Nov 10. pii: 10.1007/s00296-018-4196.
    PubMed     Abstract available


    October 2018
  166. KISIEL B, Kruszewski R, Juszkiewicz A, Raczkiewicz A, et al
    Common atherosclerosis genetic risk factors and subclinical atherosclerosis in rheumatoid arthritis: the relevance of disease duration.
    Rheumatol Int. 2018 Oct 29. pii: 10.1007/s00296-018-4186.
    PubMed     Abstract available


  167. HAYAKAWA M, Izumi K, Higashida-Konishi M, Ushikubo M, et al
    Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2018 Oct 24. pii: 10.1007/s00296-018-4175.
    PubMed     Abstract available


  168. BYKERK VP, Burmester GR, Combe BG, Furst DE, et al
    On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.
    Rheumatol Int. 2018 Oct 20. pii: 10.1007/s00296-018-4173.
    PubMed     Abstract available


  169. STEFFEN A, Holstiege J, Klimke K, Akmatov MK, et al
    Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data.
    Rheumatol Int. 2018 Oct 10. pii: 10.1007/s00296-018-4161.
    PubMed     Abstract available


  170. CASTREJON I, Shakoor N, Chua JR, Block JA, et al
    Discordance of global assessment by patients and physicians is higher in osteoarthritis than in rheumatoid arthritis: a cross-sectional study from routine care.
    Rheumatol Int. 2018 Oct 6. pii: 10.1007/s00296-018-4166.
    PubMed     Abstract available


    September 2018
  171. MUNOZ-FERNANDEZ S, Oton-Sanchez T, Carmona L, Calvo-Alen J, et al
    Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence.
    Rheumatol Int. 2018 Sep 24. pii: 10.1007/s00296-018-4152.
    PubMed     Abstract available


  172. COSKUN BENLIDAYI I
    Sleep impairment: an obstacle to achieve optimal quality of life in rheumatoid arthritis.
    Rheumatol Int. 2018 Sep 11. pii: 10.1007/s00296-018-4155.
    PubMed     Abstract available


  173. SAIKI O, Uda H
    Efficacy and safety of extending intravenous tocilizumab intervals from 4 to 6 weeks in rheumatoid arthritis patients with good response to 4-week intervals.
    Rheumatol Int. 2018 Sep 11. pii: 10.1007/s00296-018-4149.
    PubMed     Abstract available


  174. MCKENNA S, Tierney M, O'Neill A, Fraser A, et al
    Correction to: Sleep and physical activity: a cross-sectional objective profile of people with rheumatoid arthritis.
    Rheumatol Int. 2018 Sep 5. pii: 10.1007/s00296-018-4143.
    PubMed     Abstract available


  175. LEE J, Koh JH, Kim JW, Sung YK, et al
    Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome in a Korean cohort.
    Rheumatol Int. 2018;38:1651-1660.
    PubMed     Abstract available


  176. GRIFFITHS AJ, White CM, Thain PK, Bearne LM, et al
    The effect of interactive digital interventions on physical activity in people with inflammatory arthritis: a systematic review.
    Rheumatol Int. 2018;38:1623-1634.
    PubMed     Abstract available


    August 2018
  177. DEMMELMAIER I, Pettersson S, Nordgren B, Dufour AB, et al
    Associations between fatigue and physical capacity in people moderately affected by rheumatoid arthritis.
    Rheumatol Int. 2018 Aug 29. pii: 10.1007/s00296-018-4140.
    PubMed     Abstract available


  178. SAPUNDZHIEVA T, Karalilova R, Batalov A
    Musculoskeletal ultrasound for predicting remission in patients with rheumatoid arthritis: results from a 1-year prospective study.
    Rheumatol Int. 2018 Aug 18. pii: 10.1007/s00296-018-4131.
    PubMed     Abstract available


  179. OLSSON P, Skogstrand K, Nilsson A, Turesson C, et al
    Smoking, disease characteristics and serum cytokine levels in patients with primary Sjogren's syndrome.
    Rheumatol Int. 2018;38:1503-1510.
    PubMed     Abstract available


  180. KATO M, Yasuda S, Atsumi T
    The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?
    Rheumatol Int. 2018;38:1333-1338.
    PubMed     Abstract available


    July 2018
  181. YU X, Li Z, Ren M, Xi J, et al
    Superb microvascular imaging (SMI) for evaluating hand joint lesions in patients with rheumatoid arthritis in clinical remission.
    Rheumatol Int. 2018 Jul 30. pii: 10.1007/s00296-018-4112.
    PubMed     Abstract available


  182. SAWADA H, Suda M, Rokutanda R, Kobayashi D, et al
    Concomitant use of intravenous methylprednisolone to increase retention rate of abatacept in rheumatoid arthritis.
    Rheumatol Int. 2018 Jul 27. pii: 10.1007/s00296-018-4115.
    PubMed     Abstract available


  183. CEA-CALVO L, Raya E, Marras C, Salman-Monte TC, et al
    Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
    Rheumatol Int. 2018 Jul 25. pii: 10.1007/s00296-018-4113.
    PubMed     Abstract available


  184. AYRAVAINEN L, Heikkinen AM, Kuuliala A, Ahola K, et al
    Activity of rheumatoid arthritis correlates with oral inflammatory burden.
    Rheumatol Int. 2018 Jul 24. pii: 10.1007/s00296-018-4108.
    PubMed     Abstract available


  185. WALTER MJM, Kuijper TM, Hazes JMW, Weel AE, et al
    Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study.
    Rheumatol Int. 2018 Jul 16. pii: 10.1007/s00296-018-4102.
    PubMed     Abstract available


  186. YOSHIDA T, Hashimoto M, Kawahara R, Yamamoto H, et al
    Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study.
    Rheumatol Int. 2018 Jul 4. pii: 10.1007/s00296-018-4095.
    PubMed     Abstract available


    June 2018
  187. CEA-CALVO L, Raya E, Marras C, Salman-Monte TC, et al
    The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
    Rheumatol Int. 2018 Jun 29. pii: 10.1007/s00296-018-4097.
    PubMed     Abstract available


  188. SALAFFI F, Di Carlo M, Carotti M, Sarzi-Puttini P, et al
    The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia.
    Rheumatol Int. 2018 Jun 28. pii: 10.1007/s00296-018-4096.
    PubMed     Abstract available


  189. MEEK B, Kelder JC, Claessen AME, van Houte AJ, et al
    Rheumatoid factor isotype and Ro epitope distribution in primary Sjogren syndrome and rheumatoid arthritis with keratoconjunctivitis sicca.
    Rheumatol Int. 2018 Jun 23. pii: 10.1007/s00296-018-4090.
    PubMed     Abstract available


  190. VALOR L, Garrido J, Martinez-Estupinan L, Hernandez-Florez D, et al
    Identifying markers of sustained remission in rheumatoid arthritis patients on long-term tapered biological disease-modifying antirheumatic drugs.
    Rheumatol Int. 2018 Jun 18. pii: 10.1007/s00296-018-4087.
    PubMed     Abstract available


  191. CASTRO LL, Lanna CCD, Rocha MP, Ribeiro ALP, et al
    Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 Jun 15. pii: 10.1007/s00296-018-4084.
    PubMed     Abstract available


  192. GUIMARAES MFBR, de Andrade MVM, Machado CJ, Vieira ELM, et al
    Leptin as an obesity marker in rheumatoid arthritis.
    Rheumatol Int. 2018 Jun 11. pii: 10.1007/s00296-018-4082.
    PubMed     Abstract available


  193. BARCELOS F, Martins C, Papoila A, Geraldes C, et al
    Association between memory B-cells and clinical and immunological features of primary Sjogren's syndrome and Sicca patients.
    Rheumatol Int. 2018;38:1063-1073.
    PubMed     Abstract available


  194. FERNANDEZ CASTRO M, Sanchez-Piedra C, Andreu JL, Martinez Taboada V, et al
    Factors associated with severe dry eye in primary Sjogren's syndrome diagnosed patients.
    Rheumatol Int. 2018;38:1075-1082.
    PubMed     Abstract available


  195. MAVROGENI SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, et al
    Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives.
    Rheumatol Int. 2018;38:949-958.
    PubMed     Abstract available


    May 2018
  196. KABUL EG, Aslan UB, Basakci Calik B, Tasci M, et al
    Exploring the relation between impairment rating by DAS-28 and body function, activity participation, and environmental factors based on ICF hand core set in the patient with rheumatoid arthritis.
    Rheumatol Int. 2018 May 30. pii: 10.1007/s00296-018-4060.
    PubMed     Abstract available


  197. LEON L, Redondo M, Fernandez-Nebro A, Gomez S, et al
    Expert recommendations on the psychological needs of patients with rheumatoid arthritis.
    Rheumatol Int. 2018 May 28. pii: 10.1007/s00296-018-4057.
    PubMed     Abstract available


  198. LAUKOVA L, Konecna B, Vlkova B, Mlynarikova V, et al
    Anti-cytokine therapy and plasma DNA in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 May 23. pii: 10.1007/s00296-018-4055.
    PubMed     Abstract available


  199. BISKUP M, Biskup W, Majdan M, Targonska-Stepniak B, et al
    Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity.
    Rheumatol Int. 2018 May 17. pii: 10.1007/s00296-018-4053.
    PubMed     Abstract available


  200. MCKENNA SG, Donnelly AE, Esbensen BA, Fraser AD, et al
    The impact of exercise on sleep (time, quality, and disturbance) in patients with rheumatoid arthritis: a study protocol for a pilot randomised controlled trial.
    Rheumatol Int. 2018 May 15. pii: 10.1007/s00296-018-4052.
    PubMed     Abstract available


  201. UDACHKINA HV, Novikova DS, Popkova TV, Kirillova IG, et al
    Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months.
    Rheumatol Int. 2018 May 11. pii: 10.1007/s00296-018-4045.
    PubMed     Abstract available


  202. NIKFAR S, Saiyarsarai P, Tigabu BM, Abdollahi M, et al
    Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2018 May 8. pii: 10.1007/s00296-018-4041.
    PubMed     Abstract available


  203. MANDAL SK, Sandhya P, Kabeerdoss J, Ramya J, et al
    CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjogren's syndrome.
    Rheumatol Int. 2018;38:831-836.
    PubMed     Abstract available


    April 2018
  204. MEYER PWA, Ally MTM, Hodkinson B, Anderson R, et al
    Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
    Rheumatol Int. 2018 Apr 30. pii: 10.1007/s00296-018-4036.
    PubMed     Abstract available


  205. BOUTRUP RJ, Farup J, Vissing K, Kjaer M, et al
    Skeletal muscle stem cell characteristics and myonuclei content in patients with rheumatoid arthritis: a cross-sectional study.
    Rheumatol Int. 2018 Apr 12. pii: 10.1007/s00296-018-4028.
    PubMed     Abstract available


  206. DORNER TE, Berner C, Haider S, Grabovac I, et al
    Sexual health in patients with rheumatoid arthritis and the association between physical fitness and sexual function: a cross-sectional study.
    Rheumatol Int. 2018 Apr 11. pii: 10.1007/s00296-018-4023.
    PubMed     Abstract available


  207. RADOVANOVIC-DINIC B, Tesic-Rajkovic S, Zivkovic V, Grgov S, et al
    Clinical connection between rheumatoid arthritis and liver damage.
    Rheumatol Int. 2018 Apr 7. pii: 10.1007/s00296-018-4021.
    PubMed     Abstract available


  208. HIGGINS SC, Adams J, Hughes R
    Measuring hand grip strength in rheumatoid arthritis.
    Rheumatol Int. 2018 Apr 6. pii: 10.1007/s00296-018-4024.
    PubMed     Abstract available


  209. MARTIN-LOPEZ M, Carmona L, Balsa A, Calvo-Alen J, et al
    Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review.
    Rheumatol Int. 2018 Apr 3. pii: 10.1007/s00296-018-4022.
    PubMed     Abstract available


    March 2018
  210. BODAKCI E, Uskudar Cansu D, Erturk A, Calisir C, et al
    Can neck pain be an initial symptom of rheumatoid arthritis? A case report and literature review.
    Rheumatol Int. 2018 Mar 27. pii: 10.1007/s00296-018-4019.
    PubMed     Abstract available


  211. FAUTREL B, Alten R, Kirkham B, de la Torre I, et al
    Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.
    Rheumatol Int. 2018 Mar 21. pii: 10.1007/s00296-018-4005.
    PubMed     Abstract available


  212. TENTEN-DIEPENMAAT M, van der Leeden M, Vliet Vlieland TPM, Roorda LD, et al
    The effectiveness of therapeutic shoes in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2018 Mar 20. pii: 10.1007/s00296-018-4014.
    PubMed     Abstract available


  213. MCKENNA S, Tierney M, O'Neill A, Fraser A, et al
    Sleep and physical activity: a cross-sectional objective profile of people with rheumatoid arthritis.
    Rheumatol Int. 2018 Mar 14. pii: 10.1007/s00296-018-4009.
    PubMed     Abstract available


  214. SALGADO E, Maneiro Fernandez JR, Souto Vilas A, Gomez-Reino JJ, et al
    Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology.
    Rheumatol Int. 2018;38:467-472.
    PubMed     Abstract available


    February 2018
  215. MARCHI LF, Paoliello-Paschoalato AB, Oliveira RDR, Azzolini AECS, et al
    Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate.
    Rheumatol Int. 2018 Feb 20. pii: 10.1007/s00296-018-3997.
    PubMed     Abstract available


  216. HASEGAWA M, Sakai F, Konda N, Okabayashi A, et al
    CT assessment of axillary lymphadenopathy in patients with rheumatoid arthritis: association with disease activity and severity.
    Rheumatol Int. 2018 Feb 12. pii: 10.1007/s00296-018-3992.
    PubMed     Abstract available


  217. SIALA M, Rihl M, Sellami H, Znazen A, et al
    Detection of Shigella spp. nucleic acids in the synovial tissue of Tunisian rheumatoid arthritis patients and other forms of arthritis by quantitative real-time polymerase chain reaction.
    Rheumatol Int. 2018 Feb 5. pii: 10.1007/s00296-018-3939.
    PubMed     Abstract available


    January 2018
  218. LOPEZ-LONGO FJ, Seoane-Mato D, Martin-Martinez MA, Sanchez-Alonso F, et al
    Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis.
    Rheumatol Int. 2018 Jan 24. pii: 10.1007/s00296-018-3933.
    PubMed     Abstract available


  219. KARAGULLE M, Kardes S, Karagulle MZ
    Long-term efficacy of spa therapy in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 Jan 11. pii: 10.1007/s00296-017-3926.
    PubMed     Abstract available


  220. WON S, Cho SK, Kim D, Han M, et al
    Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.
    Rheumatol Int. 2018 Jan 4. pii: 10.1007/s00296-017-3925.
    PubMed     Abstract available


  221. TADA M, Inui K, Sugioka Y, Mamoto K, et al
    Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
    Rheumatol Int. 2018 Jan 2. pii: 10.1007/s00296-017-3922.
    PubMed     Abstract available


  222. SIGHART R, Rech J, Hueber A, Blank N, et al
    Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.
    Rheumatol Int. 2018;38:111-120.
    PubMed     Abstract available


    December 2017
  223. PEREZ-ROMAN DI, Ortiz-Haro AB, Ruiz-Medrano E, Contreras-Yanez I, et al
    Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.
    Rheumatol Int. 2017 Dec 20. pii: 10.1007/s00296-017-3910.
    PubMed     Abstract available


  224. FORSYTH C, Kouvari M, D'Cunha NM, Georgousopoulou EN, et al
    The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies.
    Rheumatol Int. 2017 Dec 18. pii: 10.1007/s00296-017-3912.
    PubMed     Abstract available


  225. SANTOS-MORENO P, Alvis-Zakzuk NJ, Villarreal-Peralta L, Carrasquilla-Sotomayor M, et al
    A comprehensive care program achieves high remission rates in rheumatoid arthritis in a middle-income setting. Experience of a Center of Excellence in Colombia.
    Rheumatol Int. 2017 Dec 16. pii: 10.1007/s00296-017-3903.
    PubMed     Abstract available


  226. OLIVIER N, Burger J, Joubert R, Lubbe M, et al
    Chronic disease list conditions in patients with rheumatoid arthritis in the private healthcare sector of South Africa.
    Rheumatol Int. 2017 Dec 12. pii: 10.1007/s00296-017-3907.
    PubMed     Abstract available


  227. GIANFRANCESCO MA, Yazdany J, Schmajuk G
    The impact of smoking on disease measures in rheumatoid arthritis: the need for appropriate adjustment of time-varying confounding.
    Rheumatol Int. 2017 Dec 5. pii: 10.1007/s00296-017-3902.
    PubMed     Abstract available


  228. KAMATA Y, Minota S
    Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
    Rheumatol Int. 2017 Dec 5. pii: 10.1007/s00296-017-3900.
    PubMed     Abstract available


    November 2017
  229. DO ESPIRITO SANTO RC, Pompermayer MG, Bini RR, Olszewski V, et al
    Neuromuscular fatigue is weakly associated with perception of fatigue and function in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Nov 27. pii: 10.1007/s00296-017-3894.
    PubMed     Abstract available


  230. BAGANZ L, Richter A, Kekow J, Bussmann A, et al
    Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.
    Rheumatol Int. 2017 Nov 16. doi: 10.1007/s00296-017-3870.
    PubMed     Abstract available


  231. AKYUZ G, Kenis-Coskun O
    The Efficacy of Tai Chi and Yoga in Rheumatoid Arthritis and Spondyloarthropathies: A narrative biomedical review.
    Rheumatol Int. 2017 Nov 4. doi: 10.1007/s00296-017-3867.
    PubMed     Abstract available


    October 2017
  232. UDACHKINA HV, Novikova DS, Popkova TV, Kirillova IG, et al
    Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy.
    Rheumatol Int. 2017 Oct 27. doi: 10.1007/s00296-017-3860.
    PubMed     Abstract available


  233. SKALKOU A, Manoli SM, Sachinidis A, Ntouros V, et al
    Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab.
    Rheumatol Int. 2017 Oct 26. doi: 10.1007/s00296-017-3861.
    PubMed     Abstract available


  234. TAN YK, Allen JC Jr, Lye WK, Chew LC, et al
    Greater rheumatoid arthritis joint improvement with more subjects achieving response across improvement categories using novel versus existing ultrasound methods.
    Rheumatol Int. 2017 Oct 20. doi: 10.1007/s00296-017-3857.
    PubMed     Abstract available


  235. LARKIN L, Gallagher S, Fraser A, Kennedy N, et al
    Community-based intervention to promote physical activity in rheumatoid arthritis (CIPPA-RA): a study protocol for a pilot randomised control trial.
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3850.
    PubMed     Abstract available


  236. LEE KE, Lee SS
    In reply to the letter to the Editor, "HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis".
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3851.
    PubMed    


  237. WENG J, Wu H, Wang Z
    HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis: methodological issues.
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3849.
    PubMed    


  238. KUME K, Amano K, Yamada S, Kanazawa T, et al
    Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study.
    Rheumatol Int. 2017 Oct 14. doi: 10.1007/s00296-017-3844.
    PubMed     Abstract available


  239. QUINTANA-DUQUE MA, Rondon-Herrera F, Calvo-Paramo E, Yunis JJ, et al
    The impact of smoking on disease activity, disability, and radiographic damage in rheumatoid arthritis: is cigarette protective?
    Rheumatol Int. 2017 Oct 11. doi: 10.1007/s00296-017-3845.
    PubMed     Abstract available


  240. BERNARDES M, Vieira T, Lucas R, Pereira J, et al
    Serum serotonin levels and bone in rheumatoid arthritis patients.
    Rheumatol Int. 2017 Oct 9. doi: 10.1007/s00296-017-3836.
    PubMed     Abstract available


    September 2017
  241. LEE KE, Choi SE, Xu H, Kang JH, et al
    HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 27. doi: 10.1007/s00296-017-3833.
    PubMed     Abstract available


  242. SCHIRMER M, Lion V
    Decline of rheumatologic care of nursing home residents with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 8. doi: 10.1007/s00296-017-3810.
    PubMed    


  243. SUGIMOTO N, Nakajima A, Inoue E, Shidara K, et al
    Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 7. doi: 10.1007/s00296-017-3811.
    PubMed     Abstract available


  244. SALAFFI F, Gerardi MC, Atzeni F, Batticciotto A, et al
    The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 5. doi: 10.1007/s00296-017-3792.
    PubMed     Abstract available


  245. YOON BY, Lee JH, Shin SY
    Discrepancy between subjective and objective measures of cognitive impairment in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 4. doi: 10.1007/s00296-017-3806.
    PubMed     Abstract available


    August 2017
  246. LAU CS, Gibofsky A, Damjanov N, Lula S, et al
    Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review.
    Rheumatol Int. 2017 Aug 29. doi: 10.1007/s00296-017-3780.
    PubMed     Abstract available


  247. LUQUE RAMOS A, Albrecht K, Zink A, Hoffmann F, et al
    Rheumatologic care of nursing home residents with rheumatoid arthritis: a comparison of the year before and after nursing home admission.
    Rheumatol Int. 2017 Aug 18. doi: 10.1007/s00296-017-3791.
    PubMed     Abstract available


  248. LI G, Zhao J, Li B, Ma J, et al
    Associations between CCL21 gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.
    Rheumatol Int. 2017 Aug 10. doi: 10.1007/s00296-017-3784.
    PubMed     Abstract available


    July 2017
  249. KIM D, Cho SK, Choi CB, Choe JY, et al
    Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 26. doi: 10.1007/s00296-017-3781.
    PubMed     Abstract available


  250. AZIZIEH FY, Al Jarallah K, Shehab D, Gupta R, et al
    Patterns of circulatory and peripheral blood mononuclear cytokines in rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 19. doi: 10.1007/s00296-017-3774.
    PubMed     Abstract available


  251. HIRVONEN H, Kautiainen H, Moilanen E, Mikkelsson M, et al
    The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 11. doi: 10.1007/s00296-017-3771.
    PubMed     Abstract available


  252. TAN BE, Lim AL, Kan SL, Lim CH, et al
    Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients.
    Rheumatol Int. 2017 Jul 10. doi: 10.1007/s00296-017-3772.
    PubMed     Abstract available


  253. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 5. doi: 10.1007/s00296-017-3769.
    PubMed     Abstract available


    June 2017
  254. GOH LL, Yong MY, See WQ, Chee EYW, et al
    NLRP1, PTPN22 and PADI4 gene polymorphisms and rheumatoid arthritis in ACPA-positive Singaporean Chinese.
    Rheumatol Int. 2017 Jun 26. doi: 10.1007/s00296-017-3762.
    PubMed     Abstract available


  255. MENA-VAZQUEZ N, Manrique-Arija S, Yunquera-Romero L, Urena-Garnica I, et al
    Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.
    Rheumatol Int. 2017 Jun 19. doi: 10.1007/s00296-017-3758.
    PubMed     Abstract available


  256. HUSNI ME, Betts KA, Griffith J, Song Y, et al
    Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective.
    Rheumatol Int. 2017 Jun 16. doi: 10.1007/s00296-017-3760.
    PubMed     Abstract available


  257. CARDENAS MJ, de la Fuente S, Castro-Villegas MC, Romero-Gomez M, et al
    Optimization of biological therapy in rheumatoid arthritis patients: outcomes from the CREATE registry after 2 years of follow-up.
    Rheumatol Int. 2017 Jun 9. doi: 10.1007/s00296-017-3757.
    PubMed     Abstract available


  258. PAVELKA K, Akkoc N, Al-Maini M, Zerbini CAF, et al
    Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
    Rheumatol Int. 2017 Jun 9. doi: 10.1007/s00296-017-3749.
    PubMed     Abstract available


    May 2017
  259. WEIJERS L, Baerwald C, Mennini FS, Rodriguez-Heredia JM, et al
    Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
    Rheumatol Int. 2017 May 30. doi: 10.1007/s00296-017-3739.
    PubMed     Abstract available


  260. RONDINA RG, de Mello RAF, Valim V, Lourenco RB, et al
    Discordance between clinical and imaging criteria: assessment by magnetic resonance imaging of the foot of patients with rheumatoid arthritis.
    Rheumatol Int. 2017 May 27. doi: 10.1007/s00296-017-3754.
    PubMed     Abstract available


  261. TZANETAKOS C, Tzioufas A, Goules A, Kourlaba G, et al
    Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece.
    Rheumatol Int. 2017 May 18. doi: 10.1007/s00296-017-3736.
    PubMed     Abstract available


  262. MARRAS C, Monteagudo I, Salvador G, de Toro FJ, et al
    Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.
    Rheumatol Int. 2017 May 17. doi: 10.1007/s00296-017-3737.
    PubMed     Abstract available


  263. SONG X, Lin Q
    Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis.
    Rheumatol Int. 2017 May 10. doi: 10.1007/s00296-017-3732.
    PubMed     Abstract available


  264. KABASAKAL Y, Kitapcioglu G, Karabulut G, Tezcan M, et al
    Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features.
    Rheumatol Int. 2017;37:675-684.
    PubMed     Abstract available


  265. LLORENTE I, Merino L, Ortiz AM, Escolano E, et al
    Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.
    Rheumatol Int. 2017;37:799-806.
    PubMed     Abstract available


  266. STREVENS BOLMGREN V, Olsson P, Wollmer P, Hesselstrand R, et al
    Respiratory symptoms are poor predictors of concomitant chronic obstructive pulmonary disease in patients with primary Sjogren's syndrome.
    Rheumatol Int. 2017;37:813-818.
    PubMed     Abstract available


    April 2017
  267. HUNTER TM, Boytsov NN, Zhang X, Schroeder K, et al
    Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.
    Rheumatol Int. 2017 Apr 28. doi: 10.1007/s00296-017-3726.
    PubMed     Abstract available


  268. TADA M, Inui K, Sugioka Y, Mamoto K, et al
    Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Rheumatol Int. 2017 Apr 12. doi: 10.1007/s00296-017-3720.
    PubMed     Abstract available


  269. TAN BE, Lim AL, Kan SL, Lim CH, et al
    Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
    Rheumatol Int. 2017 Apr 7. doi: 10.1007/s00296-017-3705.
    PubMed     Abstract available


  270. DE MIGUEL E, Pecondon-Espanol A, Castano-Sanchez M, Corrales A, et al
    A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Apr 7. doi: 10.1007/s00296-017-3714.
    PubMed     Abstract available


  271. NG WF, Miller A, Bowman SJ, Price EJ, et al
    Physical activity but not sedentary activity is reduced in primary Sjogren's syndrome.
    Rheumatol Int. 2017;37:623-631.
    PubMed     Abstract available


  272. GARCIA-MONTOYA L, Saenz-Tenorio CN, Janta I, Menarguez J, et al
    Hemophagocytic lymphohistiocytosis in a patient with Sjogren's syndrome: case report and review.
    Rheumatol Int. 2017;37:663-669.
    PubMed     Abstract available


    March 2017
  273. STOLT M, Suhonen R, Leino-Kilpi H
    Foot health in patients with rheumatoid arthritis-a scoping review.
    Rheumatol Int. 2017 Mar 21. doi: 10.1007/s00296-017-3699.
    PubMed     Abstract available


  274. EL-HENAWY AA, Hafez EA, Nabih N, Shalaby NM, et al
    Anti-Toxoplasma antibodies in Egyptian rheumatoid arthritis patients.
    Rheumatol Int. 2017 Mar 20. doi: 10.1007/s00296-017-3703.
    PubMed     Abstract available


    June 2016
  275. JANTA I, Moran J, Naredo E, Nieto JC, et al
    How does a cadaver model work for testing ultrasound diagnostic capability for rheumatic-like tendon damage?
    Rheumatol Int. 2016;36:863-9.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: